BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
BioCorRx Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.25+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $7.30M
- P/E (TTM)
- –
- Dividend yield
- –
BioCorRx statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Specialty Outpatient Facilities, NEC companies for comparison
Valuation
| Measure | BioCorRx | Industry median |
|---|---|---|
| Market Cap | $7.44M | $1.07B |
| Enterprise Value | $7.17M | $1.35B |
Income (trailing twelve months)
| Measure | BioCorRx | Industry median |
|---|---|---|
| Operating Income | -$4.90M | -$1.92M |
| Pretax Income | -$3.14M | -$575.82K |
| Net Income | -$3.16M | -$1.32M |
| EBITDA | -$4.93M | -$29.24K |
| EPS (Diluted) | -$0.15 | -$0.02 |
Returns
| Measure | BioCorRx | Industry median |
|---|---|---|
| Return on Assets (ROA) | -73.6% | -3.06% |
Growth
| Measure | BioCorRx | Industry median |
|---|---|---|
| Revenue Growth (3Y CAGR) | 55.1% | 10.9% |
| Revenue Growth (5Y CAGR) | 45.4% | 13.2% |
Balance sheet
| Measure | BioCorRx | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $21.24K | $47.58M |
| Net Cash (Debt) | $21.24K | $217.65K |
| Net Cash Per Share | $0.00 | $0.01 |
| Equity (Book Value) | -$12.22M | $189.59M |
| Book Value Per Share | -$0.41 | $3.32 |
| Tangible Book Value | -$13.33M | $1.72M |
| Working Capital | -$8.23M | $29.77M |
Financial position
| Measure | BioCorRx | Industry median |
|---|---|---|
| Current Ratio | 0.07 | 1.41 |
| Quick Ratio | 0.01 | 0.97 |
| Interest Coverage | -30.49 | -0.90 |
Cash flow (trailing twelve months)
| Measure | BioCorRx | Industry median |
|---|---|---|
| Operating Cash Flow | -$2.36M | $1.28M |
Efficiency
| Measure | BioCorRx | Industry median |
|---|---|---|
| Profits Per Employee | -$1.05M | -$5.96K |
| Employee Count | 3 | 897 |
Dividends and yields
| Measure | BioCorRx | Industry median |
|---|---|---|
| Earnings Yield | -42.5% | -1.25% |
Shares
| Measure | BioCorRx | Industry median |
|---|---|---|
| Shares Outstanding | 29,758,200 | 58,609,450 |
| Shares Change (YoY) | 72.6% | 2.64% |
| Shares Change (QoQ) | 2.63% | 0.29% |
| Float | 26,126,400 | 34,865,600 |
| Shares Held by Insiders | 12.2% | 16.6% |
Scores
| Measure | BioCorRx | Industry median |
|---|---|---|
| Altman Z-Score | -78.35 | 1.98 |
| Piotroski F-Score | 5 | 5 |
Calculated by StockData from BioCorRx's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.